India · Delayed Price · Currency is INR NATCO Pharma Company Description
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.
The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services.
In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF.
Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops.
NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
| Country | India |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 4,016 |
| CEO | Rajeev Nannapaneni |
Contact Details
Address: Natco House Hyderabad, 500034 India | |
| Phone | 91 40 2354 7532 |
| Website | natcopharma.co.in |
Stock Details
| Ticker Symbol | 524816 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rajeev Nannapaneni | Chief Executive Officer |
| S. V. V. Appa Rao | Chief Financial Officer |
| Nadella Rao | Chief Operating Officer |